LENZ Therapeutics, Inc. (LENZ) Insider Ownership

Historic Insider Ownership Trends

LENZ Therapeutics's top three insider shareholders as of April 25, 2026 are Biocapital, L.P. Samsara (TenPercentOwner, 8.46Mn shares), Biocapital, L.P. Samsara (TenPercentOwner, 8.46Mn shares), Biocapital, L.P. Samsara (TenPercentOwner, 8.46Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Biocapital, L.P. Samsara - 0 8,459,314 13 Apr, 2022
Biocapital, L.P. Samsara - 0 8,459,314 13 Apr, 2022
Biocapital, L.P. Samsara - 0 8,459,314 13 Apr, 2022
Biocapital, L.P. Samsara - 0 8,459,314 13 Apr, 2022
Biocapital, L.P. Samsara - 0 8,034,850 25 Jan, 2022
Biocapital, L.P. Samsara - 0 8,034,850 25 Jan, 2022
Biocapital, L.P. Samsara - 0 8,034,850 25 Jan, 2022
Biocapital, L.P. Samsara - 0 8,034,850 25 Jan, 2022
Capital Management, L.P. Ra - 0 4,014,094 25 Mar, 2024
Venture Capital Vi, L.P. Versant - 1,050,599 764,127 02 Oct, 2025
Davis Jerel - 0 1,707,719 01 Jul, 2021
Venture Capital Vi, L.P. Versant - 0 1,047,912 20 Jun, 2025
Capital Management, L.P. Ra - 0 694,755 25 Mar, 2024
James W Mccollum - 0 525,565 14 May, 2024
Phil Gutry Chief Business Officer 299,941 0 13 Apr, 2022
Marc Odrich Chief Medical Officer 99,599 0 25 Mar, 2024
Evert B. Schimmelpennink President, Ceo And Secretary 77,289 0 30 Mar, 2026
Biocapital, L.P. Samsara - 0 37,753 01 Jul, 2021
Daniel R. Chevallard Chief Financial Officer 12,886 0 30 Mar, 2026
James W Mccollum - 10,500 0 10 Nov, 2025
Jeffrey P. George - 5,592 0 30 Mar, 2026
Shawn Olsson Chief Commercial Officer 4,733 0 19 Nov, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
27 Mar, 2026 Daniel R. Chevallard Common Stock A 7,500 $8.57 12,886 D P
27 Mar, 2026 Evert B. Schimmelpennink Common Stock A 28,089 $8.95 77,289 D P
27 Mar, 2026 Jeffrey P. George Common Stock A 5,592 $8.92 5,592 D P
02 Jan, 2026 Shawn Olsson Stock Option (right to buy) A 84,200 $0.00 84,200 D A
02 Jan, 2026 Marc Odrich Stock Option (right to buy) A 84,200 $0.00 84,200 D A
02 Jan, 2026 Evert B. Schimmelpennink Stock Option (right to buy) A 358,100 $0.00 358,100 D A
02 Jan, 2026 Daniel R. Chevallard Stock Option (right to buy) A 84,200 $0.00 84,200 D A
02 Jan, 2026 Shawn Olsson Restricted Stock Unit A 14,000 $0.00 14,000 D A
02 Jan, 2026 Marc Odrich Restricted Stock Unit A 14,000 $0.00 14,000 D A
02 Jan, 2026 Daniel R. Chevallard Restricted Stock Unit A 14,000 $0.00 14,000 D A
17 Nov, 2025 Shawn Olsson Common Stock A 10,000 $2.08 14,733 D M
17 Nov, 2025 Shawn Olsson Common Stock D 4,212 $25.74 10,521 D S
17 Nov, 2025 Shawn Olsson Common Stock D 5,788 $26.37 4,733 D S
17 Nov, 2025 Shawn Olsson Stock Option (right to buy) D 10,000 $0.00 53,241 D M
07 Nov, 2025 James W Mccollum Common Stock A 10,500 $22.79 10,500 D P
07 Nov, 2025 Daniel R. Chevallard Common Stock A 20 $22.71 3,208 D P
07 Nov, 2025 Daniel R. Chevallard Common Stock A 2,178 $22.76 5,386 D P
30 Sep, 2025 Venture Capital Vi, L.P. Versant Common Stock D 49,701 $45.35 1,133,842 D S
30 Sep, 2025 Venture Capital Vi, L.P. Versant Common Stock D 34,405 $45.35 821,752 I S
30 Sep, 2025 Venture Capital Vi, L.P. Versant Common Stock D 83,066 $46.41 1,050,776 D S